Ignite Creation Date:
2024-07-17 @ 11:14 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06478355
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-27
First Post:
2024-06-13
Brief Title:
Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell CarcinomaChinECR
Sponsor:
Hebei Medical University Fourth Hospital
Organization:
Hebei Medical University Fourth Hospital
Organization Data
Organization:
Hebei Medical University Fourth Hospital
Class:
OTHER
Study ID:
2024KY167
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hebei Medical University Fourth Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None